Skip to content

Phastar announced as Networking Sponsor for ACDM20

Date: July 9, 2019

The ACDM are delighted to announce that Phastar are to be Networking & Conference Dinner Sponsor for ACDM20. ACDM20 is at Clontarf Castle, Dublin from the 9-10 March 2020. Sheelagh Aird Head of Clinical Data Management said: PHASTAR is sponsoring and exhibiting at ACDM20 in order to share the recent developments within our machine learning, artificial intelligence and clinical data management department, including a partnership with Medidata and our continued work with Medrio. ACDM20 will also provide an opportunity to discuss best practise with Data Managers across the pharmaceutical, biotechnology and medical device industry. Following the success of last year’s event, PHASTAR will be sponsoring the dinner and networking evening, which provides a chance for attendees to relax, catch up with old friends and hopefully make some new ones.

For full details of sponsorship and exhibition opportunities for ACDM20 click here: https://acdmconference.org/acdm20-sponsorship-exhibition-opportunities-3/

 


 

Explore More News

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Read More

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Read More

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Read More

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .

Read More

Newsletter Committee: Meet Marta

The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .

Read More

AI model trained on de-identified data from 57 million people

Researchers at UCL have trained an AI model using de-identified data from 57 million . . .

Read More

ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released

The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .

Read More

ICH E6(R3) Guideline reaches Step 4 of the ICH Process

ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025. The guideline . . .

Read More

U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties

The U.S. Food and Drug Administration has issued its first guidance on the use of . . .

Read More

ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025

As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .

Read More

Audit Trail Review DMEG Update – New Guide

The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a . . .

Read More

Risk Based Quality Management DMEG Update – Recent Discussions

This year our focus has switched away from generalised RBQM to applying risk-based . . .

Read More